Helicos

The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.

The company is currently working with three hospitals in China and plans to launch the GenoCare system commercially in 2017.

This article was originally published Sept. 29.

NEW YORK (GenomeWeb) – Startup SeqLL has closed a $1 million Series A financing round, which it said it will use to enhance Helicos BioSciences' single-molecule sequencing technology for scientific and diagnostic applications. Genomic Diagnostic Technologies led the investment.

Authors of a recent study in BMC Research Notes have concluded that archeological control testing and targeted verification testing are key to avoiding false-positive pathogen identification when

NEW YORK (GenomeWeb News) – Researchers at Brown University and the St. Laurent Institute have found ties between RNA editing and transposon-related gene silencing in fruit flies — findings that they suspect may extend to other organisms.

NEW YORK (GenomeWeb News) – The US bankruptcy court in charge of Helicos BioSciences' Chapter 11 bankruptcy reorganization has approved deals for the company to license its intellectual pr

NEW YORK (GenomeWeb News) – Defunct next-generation sequencing technology firm Helicos BioSciences has asked a bankruptcy court to approve the licensing of intellectual property to Illumina, Life Technologies, and Fluidigm.

NEW YORK (GenomeWeb News) – Helicos BioSciences, currently in Chapter 11 bankruptcy protection, is seeking approval from bankruptcy court to sell its assets to an employee who plans to for

Helicos will be able to use cash collateral, at least on an interim basis, to continue funding its operations as it navigates its way through the bankruptcy process and attempts to sell off its intellectual property, according to an order issued last month from the US Bankruptcy

Pages

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.